Як цитувати

Plesacov, A., Vladanov, I., & Ghicavii, V. (2021). HIGH POWER TRANSURETHRAL THULIUM:YAG LASER VAPOENUCLEATION OF PROSTATE – A NEW STANDARD IN BENIGN PROSTATE HYPERPLASIA SURGERY. InterConf, (46), 281-289. https://doi.org/10.51582/interconf.19-20.03.2021.027


According to current reccomandations, open adenomectomy is considered the most efficient surgical option for patients with large benign prostatic hyperplasia. In order to reduce surgical trauma and to improuve postoperative recovery, there have been proposed several minimally invasive techniques for the treatment of large benign prostatic hyperplasia, the most innovative being laser surgery. High power Thulium:YAG laser vapoenucleation of prostate is becoming popular for minimal invasive surgical management of benign prostate hyperplasia.



N. L, L.-B. M, F. H, G.-L. H, H. W, G.-Z. L, et al. Multiple factors related to detrusor overactivity in Chinese patients with benign prostate hyperplasia. Chin Med J (Engl). 2012;

Herrmann T, Liatsikos E, Nagele U, Traxer O, Merseburger A. EAU guidelines panel on lasers,technologies. EAU guidelines on laser technologies. Eur Urol. 2012;

T. B, C. N, L. P, T.R.W. H, A.J. G. Thulium:YAG vapoenucleation in large volume prostates. Journal of Urology. 2011.

Gross AJ, Netsch C, Knipper S, Hölzel J, Bach T. Complications and early postoperative outcome in 1080 patients after thulium vapoenucleation of the prostate: Results at a single institution. Eur Urol. 2013;

Netsch C, Engbert A, Bach T, Gross AJ. Long-term outcome following Thulium VapoEnucleation of the prostate. World J Urol. 2014;

Chang CH, Lin TP, Chang YH, Huang WJ, Lin AT, Chen KK. Vapoenucleation of the prostate using a high-power thulium laser: A one-year follow-up study. BMC Urol. 2015;

Hauser S, Rogenhofer S, Ellinger J, Strunk T, Müller SC, Fechner G. Thulium laser (Revolix) vapoenucleation of the prostate is a safe procedure in patients with an increased risk of hemorrhage. Urol Int. 2012;

Netsch C, Pohlmann L, Herrmann TRW, Gross AJ, Bach T. 120-W 2-μm thulium:yttrium-aluminium-garnet vapoenucleation of the prostate: 12-Month follow-up. BJU Int. 2012;

Hong K, Liu YQ, Lu J, Xiao CL, Huang Y, Ma LL. Efficacy and safety of 120‑W thulium: Yttrium‑aluminum‑garnet vapoenucleation of prostates compared with holmium laser enucleation of prostates for benign prostatic hyperplasia. Chin Med J (Engl). 2015;

Bach T, Huck N, Wezel F, Häcker A, Gross AJ, Michel MS. 70 vs 120 W thulium: Yttrium-aluminium-garnet 2 μm continuous-wave laser for the treatment of benign prostatic hyperplasia: A systematic ex-vivo evaluation. BJU Int. 2010;

Netsch C, Bach T, Herrmann TR, Gross AJ. Thulium:YAG VapoEnucleation of the prostate in large glands: A prospective comparison using 70- and 120-W 2-νm lasers. Asian J Androl. 2012;

Bach T, Muschter R, Sroka R, Gravas S, Skolarikos A, Herrmann TRW, et al. Laser treatment of benign prostatic obstruction: Basics and physical differences. European Urology. 2012.

Bach T, Netsch C, Haecker A, Michel MS, Herrmann TRW, Gross AJ. Thulium:YAG laser enucleation (VapoEnucleation) of the prostate: Safety and durability during intermediate-term follow-up. World J Urol. 2010;

Sun DC, Yang Y, Wei ZT, Hong BF, Zhang X. Transurethral dividing vaporesection for the treatment of large volume benign prostatic hyperplasia using 2 micron continuous wave laser. Chin Med J (Engl). 2010;

Y. X, D.C. S, Y. Y, Z.T. W, B.F. H, X. Z. [5-year follow-up to transurethral vaporesection of the prostate using the 2 micron continuous wave laser for the treatment of benign prostatic hyperplasia]. Zhonghua Wai Ke Za Zhi. 2013;

Creative Commons License

Ця робота ліцензується відповідно до Creative Commons Attribution 4.0 International License.


Дані завантаження ще не доступні.

| Переглядів: 22 | Завантажень: 49 |